101 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink 103 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED) link:calculationLink link:presentationLink link:definitionLink 104 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) link:calculationLink link:presentationLink link:definitionLink 105 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) link:calculationLink link:presentationLink link:definitionLink 106 - Disclosure - Basis of Presentation link:calculationLink link:presentationLink link:definitionLink 107 - Disclosure - Adoption of New Accounting Policies link:calculationLink link:presentationLink link:definitionLink 108 - Disclosure - Acquisition of King Pharmaceuticals, Inc. link:calculationLink link:presentationLink link:definitionLink 109 - Disclosure - Discontinued Operations link:calculationLink link:presentationLink link:definitionLink 110 - Disclosure - Costs Associated with Cost-Reduction and Productivity Initiatives and Acquisition Activity link:calculationLink link:presentationLink link:definitionLink 111 - Disclosure - Other (Income)/Deductions-Net link:calculationLink link:presentationLink link:definitionLink 112 - Disclosure - Taxes on Income link:calculationLink link:presentationLink link:definitionLink 113 - Disclosure - Comprehensive Income/(Loss) link:calculationLink link:presentationLink link:definitionLink 114 - Disclosure - Financial Instruments link:calculationLink link:presentationLink link:definitionLink 115 - Disclosure - Inventories link:calculationLink link:presentationLink link:definitionLink 116 - Disclosure - Goodwill and Other Intangible Assets link:calculationLink link:presentationLink link:definitionLink 117 - Disclosure - Pension and Postretirement Benefit Plans link:calculationLink link:presentationLink link:definitionLink 118 - Disclosure - Earnings Per Share Attributable to Common Shareholders link:calculationLink link:presentationLink link:definitionLink 119 - Disclosure - Legal Proceedings and Contingencies link:calculationLink link:presentationLink link:definitionLink 120 - Disclosure - Segment, Product and Geographic Area Information link:calculationLink link:presentationLink link:definitionLink 121 - Disclosure - Adoption of New Accounting Policies (Policies) link:calculationLink link:presentationLink link:definitionLink 122 - Disclosure - Acquisition of King Pharmaceuticals, Inc. (Tables) link:calculationLink link:presentationLink link:definitionLink 123 - Disclosure - Discontinued Operations (Tables) link:calculationLink link:presentationLink link:definitionLink 124 - Disclosure - Costs Associated with Cost-Reduction and Productivity Initiatives and Acquisition Activity (Tables) link:calculationLink link:presentationLink link:definitionLink 125 - Disclosure - Other (Income)/Deductions-Net (Tables) link:calculationLink link:presentationLink link:definitionLink 126 - Disclosure - Comprehensive Income/(Loss) (Tables) link:calculationLink link:presentationLink link:definitionLink 127 - Disclosure - Financial Instruments (Tables) link:calculationLink link:presentationLink link:definitionLink 128 - Disclosure - Inventories (Tables) link:calculationLink link:presentationLink link:definitionLink 129 - Disclosure - Goodwill and Other Intangible Assets (Tables) link:calculationLink link:presentationLink link:definitionLink 130 - Disclosure - Pension and Postretirement Benefit Plans (Tables) link:calculationLink link:presentationLink link:definitionLink 131 - Disclosure - Earnings Per Share Attributable to Common Shareholders (Tables) link:calculationLink link:presentationLink link:definitionLink 132 - Disclosure - Segment, Product and Geographic Area Information (Tables) link:calculationLink link:presentationLink link:definitionLink 133 - Disclosure - Basis of Presentation Narrative (Detail) link:calculationLink link:presentationLink link:definitionLink 134 - Disclosure - Acquisition of King Pharmaceuticals, Inc. Narrative (Detail) link:calculationLink link:presentationLink link:definitionLink 135 - Disclosure - Acquisition of King Pharmaceuticals Inc - Assets Acquired and Liabilities Assumed (Detail) link:calculationLink link:presentationLink link:definitionLink 136 - Disclosure - Acquisition of King Pharmaceuticals Inc - Included In Consolidated Statements of Income (Detail) link:calculationLink link:presentationLink link:definitionLink 137 - Disclosure - Acquisition of King Pharmaceuticals Inc - Pro Forma Information (Detail) link:calculationLink link:presentationLink link:definitionLink 138 - Disclosure - Discontinued Operations Narrative (Detail) link:calculationLink link:presentationLink link:definitionLink 139 - Disclosure - Discontinued Operations - Net of Tax in Condensed Consolidated Statements of Income (Detail) link:calculationLink link:presentationLink link:definitionLink 140 - Disclosure - Discontinued Operations - Assets of Discontinued Operations and Other Assets Held for Sale and Liabilities of Discontinued Operations in Condensed Consolidated Balance Sheets (Detail) link:calculationLink link:presentationLink link:definitionLink 141 - Disclosure - Costs Associated with Cost-Reduction and Productivity Initiatives and Acquisition Activity (Detail) link:calculationLink link:presentationLink link:definitionLink 142 - Disclosure - Costs Associated with Cost-Reduction and Productivity Initiatives and Acquisition Activity - Restructuring Charges (Detail) link:calculationLink link:presentationLink link:definitionLink 143 - Disclosure - Other (Income)/Deductions - Net (Detail) link:calculationLink link:presentationLink link:definitionLink 144 - Disclosure - Taxes on Income Narrative (Detail) link:calculationLink link:presentationLink link:definitionLink 145 - Disclosure - Comprehensive Income/(Loss) (Detail) link:calculationLink link:presentationLink link:definitionLink 146 - Disclosure - Financial Instruments Assets and Liabilities Measured on Recurring Basis (Detail) link:calculationLink link:presentationLink link:definitionLink 147 - Disclosure - Financial Instruments by Balance Sheet Grouping (Detail) link:calculationLink link:presentationLink link:definitionLink 148 - Disclosure - Financial Instruments by Balance Sheet Grouping (Parenthetical) (Detail) link:calculationLink link:presentationLink link:definitionLink 149 - Disclosure - Financial Instruments - Investments in Debt Securities (Detail) link:calculationLink link:presentationLink link:definitionLink 150 - Disclosure - Financial Instruments Narrative (Detail) link:calculationLink link:presentationLink link:definitionLink 151 - Disclosure - Financial Instruments - Derivative Financial Instruments and Hedging Activities (Detail) link:calculationLink link:presentationLink link:definitionLink 152 - Disclosure - Inventories (Detail) link:calculationLink link:presentationLink link:definitionLink 153 - Disclosure - Goodwill and Other Intangible Assets-Goodwill (Detail) link:calculationLink link:presentationLink link:definitionLink 154 - Disclosure - Goodwill and Other Intangible Assets - Finite-lived and Indefinite-lived intangible assets (Detail) link:calculationLink link:presentationLink link:definitionLink 155 - Disclosure - Goodwill and Other Intangible Assets Narrative (Detail) link:calculationLink link:presentationLink link:definitionLink 156 - Disclosure - Pension and Postretirement Benefit Plans (Detail) link:calculationLink link:presentationLink link:definitionLink 157 - Disclosure - Pension and Postretirement Benefit Plans Narrative (Detail) link:calculationLink link:presentationLink link:definitionLink 158 - Disclosure - Earnings Per Share Diluted Numerator (Detail) link:calculationLink link:presentationLink link:definitionLink 159 - Disclosure - Earnings Per Share Attributable to Common Shareholders - Basic Numerator (Detail) link:calculationLink link:presentationLink link:definitionLink 160 - Disclosure - Legal Proceedings and Contingencies Narrative (Detail) link:calculationLink link:presentationLink link:definitionLink 161 - Disclosure - Segment, Product and Geographic Area Information Narrative (Detail) link:calculationLink link:presentationLink link:definitionLink 162 - Disclosure - Segment, Product and Geographic Area Information (Detail) link:calculationLink link:presentationLink link:definitionLink 163 - Disclosure - Segment, Product and Geographic Area Information - Revenues By Products (Detail) link:calculationLink link:presentationLink link:definitionLink 164 - Disclosure - Segment, Product and Geographic Area Information - Revenues By Geographic Area (Detail) link:calculationLink link:presentationLink link:definitionLink